Journal
NUTRIENTS
Volume 12, Issue 6, Pages -Publisher
MDPI
DOI: 10.3390/nu12061849
Keywords
parenteral nutrition; pediatrics; amino acids; cysteine; N-acetylcysteine; N; N-diacetylcystine
Categories
Funding
- Pharm Dev B. Braun Medical
Ask authors/readers for more resources
The ESPGHAN/ESPEN/ESPR-Guidelines on pediatric parenteral nutrition (PPN) recommend the administration of the semiessential amino acid (AA) cysteine to preterm neonates due to their biochemical immaturity resulting in an inability to sufficiently synthetize endogenous cysteine. The soluble precursorN-acetylcysteine (NAC) is easily converted into bioavailable cysteine. Its dimerN,N-diacetylcystine (DAC) is almost unconvertable to cysteine when given intravenously resulting in a diminished bioavailability of cysteine. This study aims to understand the triggers and oxidation process of NAC to DAC to evaluate possibilities of reducing DAC formation in standardized PPN. Therefore, different air volumes (21% O-2) were injected into the AA compartment of a standardized dual-chamber PPN. O(2)concentrations were measured in the AA solution and the headspaces of the primary and secondary packaging. NAC and DAC concentrations were analyzed simultaneously. The analysis showed that O(2)is principally delivered from the primary headspace. NAC oxidation exclusively delivers DAC, depending on the O(2)amount in the solution and the headspaces. The reaction of NAC to DAC being containable by limiting the O(2)concentration, the primary headspace must be minimized during manufacturing, and oxygen absorbers must be added into the secondary packaging for a long-term storage of semipermeable containers.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available